Roche diabetes drug beats Januvia in Phase III - FierceBiotech
Links shared publicly online about this topic.
- 1,560total visits
Roche diabetes drug beats Januvia in Phase III - FierceBiotech
Roche rolled out data from a pair of Phase III trials of its experimental diabetes drug taspoglutide, saying that researchers have nailed down its superiority to Merck's blockbuster Januvia. The Read more...
View full resource at fiercebiotech.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Januvia, Merck & Co., News
Most Recently Shared on December 2, 2009 at 12:55 pm By:
BREAKING NEWS: Roche diabetes drug taspoglutide beats Januvia in Phase III. http://is.gd/59YIY
Advertisement
